UGT2B37 Inhibitors

Chemical inhibitors of UGT2B37 can exert their inhibitory effects through various direct interactions with the enzyme's active site. Chrysin, for instance, competes with the endogenous substrates of UGT2B37, effectively reducing the enzyme's glucuronidation activity by occupying the binding sites needed for catalysis. Similarly, flavone inhibits the activity of UGT2B37 by directly interacting with its active site, which prevents the enzyme from processing substrates. This type of inhibition is also seen with naringenin, which occupies the active site of UGT2B37 and thus prohibits the enzyme's catalytic action on its substrates.

Several other flavonoids, such as baicalein, hesperetin, quercetin, kaempferol, myricetin, genistein, biochanin A, apigenin, and luteolin, demonstrate their inhibitory effect on UGT2B37 through similar mechanisms. Baicalein, for instance, binds directly to UGT2B37, which disrupts the attachment of glucuronic acid to lipophilic molecules, a key step in the glucuronidation process. Hesperetin and quercetin act as competitive inhibitors, contending with the natural substrates of UGT2B37 for binding on the enzyme's active site, leading to a decrease in the enzyme's activity. Kaempferol and myricetin, through their binding to the active site, hinder the glucuronidation process that UGT2B37 facilitates. Genistein and biochanin A also exhibit their inhibitory action by directly interacting with the active site of UGT2B37, thereby impeding the transfer of glucuronic acid to substrates. Lastly, apigenin and luteolin inhibit UGT2B37 by binding to the active site, blocking the catalytic site, and therefore, preventing the glucuronidation of the enzyme's substrates. Each of these chemicals can effectively inhibit UGT2B37 by directly binding to the enzyme and obstructing its normal function without affecting the expression or transcription of the protein.